Skip To Content
 

Diagnostic Imaging Pathways - Cushing's Syndrome

PathwaysHome
Flow Chart
Image gallery
Teaching Points
References
PDF Version

References

  1. Goldfarb DA. Contemporary evaluation and management of Cushing's syndrome. World J Urol 1999;17:22-5. (Review article)
  2. Boscharo M, Barzon L, Fallo F, et al. Cushing's syndrome. Lancet 2001;357:783-91.
  3. Newell-Price J, Jorgensen JOL, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome. Hormone Research 1999;51(S3):81-94.
  4. Ross RJM, Trainer PJ. Endocrine investigation: Cushing's syndrome. Clinical Endocrinology 1998;49:153-5.
  5. Kaye TB, Crapo L. The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 1990;112:434-44. (Level II evidence). Click here to view reference
  6. Buchfelder M, Nistor R, Fahlbusch R, et al. The accuracy of CT and MR evaluation of the sella turcica for detection of adrenocorticotropic hormone-secreting adenomas in Cushing disease. AJNR 1993;14:1183-90. (Level III evidence)
  7. Peck WW, Dillon WP, Norman D, et al. High resolution MR imaging of pituitary microadenomas at 1.5T: experience with Cushing's disease. AJR 1989;152:145-51. (Level III evidence)
  8. De Herder WW, Uitterlinden P, Pieterman H, et al. Pituitary tumour localisation in patients with Cushing's disease by magnetic resonance imaging: is there a place for petrosal sinus sampling? Clin Endocrinology (Oxf) 1994;40:87-92.
  9. Colombo N, Loli P, Vignati F, et al. MR of corticotropic-secreting pituitary microadenomas. AJNR 1994;15:1591-5. (Level IV evidence)
  10. Doppman JL, Frank JA, Dwyer AJ, et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J Comput Assist Tomogr 1988;12:728-35. (Level IV evidence)
  11. Oldfield EH, Doppman JL, Nieman LK, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. NEJM 1991;325;897-905. (Level III evidence)
  12. Daitich JA, Goldfarb DA, Novick AC. Cleveland clinic experience with adrenal Cushing's syndrome. J Urol 1997;158:2051-5. (Level III evidence)
  13. Mengden T, Hubmann P, Muller J et al. Urinary free cortisol versus 17-hydroxycorticosteroids: a comparative study of their diagnostic value in Cushing's Syndrome Clinical Invest 1992; 70(7): 545-548 (Level III Evidence)
  14. Findling J, Raff Hershel Cushing's Syndrome: Important Issues in Diagnosis and Management J Clin Endocrinol Metab 2006; 91(10):3746-3753 (Review Article)

Further Reading

  1. Cushing syndrome. Current Probl Surg, July 2001;489-545.

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you might need to download Adobe® Acrobat Reader.

Get Adobe Reader